RPL17 and non-small cell lung carcinoma: In this study, we performed objective quantitative measurements of PD-L1 expression per unit area of tumor tissue by PID staining (PD-L1 PID score) in five patients with non-small cell lung cancer (three responders and two non-responders) treated with anti- PD-1 antibody.